Lawmakers Request Information on Rising Insulin Prices

Drug Industry Daily
A A
As the new Congress looks for ways to address high drug prices, two prominent lawmakers asked Eli Lilly, Novo Nordisk and Sanofi to explain the soaring prices of their insulin products.

To View This Article:

Login

Subscribe To Drug Industry Daily